Navigation Links
Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
Date:4/9/2013

Research. In separate discussions, the FDA has advised that EEC data will be accepted as part of pivotal registration trials. Inflamax has several studies in the planning stages which incorporate the mobile EEC technology in hybrid Field/EEC studies which incorporate EEC visits into the traditional allergy field study. Inflamax, on its own will begin the work immediately to set up an Investigator network to conduct the international study across three locations in the US and Canada using Inflamax’s proprietary mobile Environmental Exposure Chamber (mEEC™) system.

Inflamax Research’s mEEC™ system is a patent pending technology developed by Inflamax that allows the incorporation of EEC visits in any field allergic rhinitis study. Mobile EECs are designed such that an EEC site can be positioned at any location worldwide. Once a site is finalized the mobile EEC can be set up in as little as one week. Data collected in the EEC has been shown to be more discriminative, accurate, precise and less variable then data collected in traditional field seasonal or perennial rhinitis studies. Lower data variability also permits studies to have smaller sample sizes leading to cost and time efficiencies in drug development.

About Inflamax

Inflamax is a full service Contract Research Organization (CRO) specializing in Proof of Concept as well as Phase I through IV studies in allergy, asthma, ocular and dermatology utilizing EEC technology. Inflamax conducts single and multi-center Environmental Exposure Chamber (EEC) and field studies. In addition to Inflamax Research’s Mobile EEC(TM) systems which can be positioned globally, Inflamax has 2 fixed EECs at Inflamax headquarters in Toronto, Canada. Inflamax’s EECs have been validated for the study of allergy to ragweed, grass and dry eye syndrome (utilizing low humidity EEC conditions). Validations are currently in process for cat and dust mite allergens and are expected to be completed in Q2’2013, thereby maki
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
2. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
3. Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
4. China Industry Reports: 2013 Research on Swine Industry Chain, Human Tetanus Immunoglobulin, Power Energy Storage Battery and Wind Power Lubricating Grease at ReportsnReports.com
5. Manchester leads the way in graphene membrane research
6. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
7. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
8. Solution Styrene Butadiene Rubber (S-SBR) Market is Expected to Reach USD 3.2 Billion in 2018: Transparency Market Research
9. Elsevier and the Belarus Ministry of Education Honor Researchers with Scopus Awards
10. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
11. Beekeepers, Researchers and Bayer CropScience Associate Overwintering Bee Losses with Varroa Mite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 26, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Molecular ... to their offering. This report ... that will play an important role in ... forensics and biological warfare in the 21st ...
(Date:5/27/2015)... Expanding in a big way into the ... Inc. recently inked a deal with Arthur Mokuda, ... , the largest endodontic distributor in Japan. The move ... Avalon Biomed, which manufactures Grey MTA Plus® and the ... that have won renown from dentists around the world. ...
(Date:5/27/2015)... 2015 The ALS Therapy Development ... wholly owned subsidiary, Anelixis Therapeutics , $1.5 million ... that targets the innate immune system. The funding comes ... received from the 2014 social media phenomenon known as ... $4 million raised directly by the Institute through last ...
(Date:5/27/2015)... , May 27, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... DCVax® personalized immune therapies for cancer, announced today that ... of the Company, will be making an Industry Expert ... Chicago on Saturday, May 30, ... Industry Expert Theater in McCormick Place. Dr. ...
Breaking Biology Technology:Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3
... Dec. 27, 2011  United Therapeutics Corporation (NASDAQ: ... Therapeutics Europe, Ltd., announced today that the French ... des Produits de Sante (AFSSAPS) has approved ... of pulmonary arterial hypertension (PAH).  Remodulin is already ...
... Pacific Meso Center (PMC) at the Pacific Heart, ... of $100,000 from Roger and Ann Worthington. Mr. Worthington ... Roger G. Worthington, PC, an asbestos law firm in ... laboratory in Santa Monica, California. The new state-of-the-art mesothelioma ...
... Inc. (Inspiration), the only biopharmaceutical company focused exclusively ... options for people with hemophilia, announced today the ... MA from Laguna Niguel, CA.  The move is ... future staffing and facility needs as the Company ...
Cached Biology Technology:Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 2Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 3Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 4Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 5Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles 2Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts 2Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts 3
(Date:5/26/2015)... , May 26, 2015 ... announced the addition of the "Saudi Arabia ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... Arabia is projected to grow at ... high growth is attributed to the surging demand ...
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... A group of Texas-based researchers provided answers for the ... very short window by the U.S. Environmental Protection Agency ... The EPA issued a final ruling on Dec. 18 ... these gases by large confined animal feeding operations to ...
... screwing up your responsibility by firing science and environment ... do this," said climate researcher and policy analyst Stephen ... of global warming and related issues. Schneider, a coordinating ... the Intergovernmental Panel on Climate Change published in 2007, ...
... Our ability to conserve and protect wildlife is at ... environment is changing over time,says new research out today ... shows that people may not realise species are declining ... changed,dramatically since their parents, and grandparents, days, and even ...
Cached Biology News:Texas researchers provide emissions data for livestock industry 2Texas researchers provide emissions data for livestock industry 3Texas researchers provide emissions data for livestock industry 4Mass media often failing in its coverage of global warming, says climate researcher 2Mass media often failing in its coverage of global warming, says climate researcher 3Village bird study highlights loss of wildlife knowledge from one 2Village bird study highlights loss of wildlife knowledge from one 3
A simple, sensitive and reliable method for determining free sulfhydryl content in peptides, protein...
... is designed for stabilizing the coating ... for immunoassay development. It can ... coating and drying process and for ... also works as a blocking agent ...
... Digital shaking water bath, with a comprehensive ... and shaking water baths with seamless, splash-water ... The bright MULTI-DISPLAY (LED) indicating up to ... the lab. Advanced MICROPROCESSOR technology with PID ...
... new TC-412 thermal cycler, flexible on your protocols, ... a high performance, high sample throughput instrument at ... Flexible block format: The truly user-friendly fully ... in a matter of seconds without the need ...
Biology Products: